EUCTR2015-003548-38-DK进行中（未招募）1 期
CLOpidogrel response and CYP2C19 Genotype in Ischemic Stroke patients
Roskilde Hospital0 个研究点开始时间: 2015年8月12日最近更新:
适应症
相关药物
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional clinical trial of medicinal product
入排标准
- 性别
- All
入选标准
- •Ischemic stroke patients
- •Treatment with Clopidogrel 75 mg/day
- •Are the trial subjects under 18? no
- •Number of subjects for this age range:
- •F.1.2 Adults (18-64 years) yes
- •F.1.2.1 Number of subjects for this age range 20
- •F.1.3 Elderly (>=65 years) yes
- •F.1.3.1 Number of subjects for this age range 83
排除标准
- •treatment with other antiplatelet drug
- •known cancer disease
- •Pregnancy or breastfeeding
研究者
相似试验
已完成
1 期
Influence of CYP2C19 Genetic Variants on Clopidogrel in Healthy SubjectsHealthyNCT00413608Assistance Publique - Hôpitaux de Paris140
Unknown
不适用
Correlation Between CYP2C19 Genotype, Level Of Clopidogrel Metabolite And Platelet Inhibition StatusPRIMARY FOCUS:PATIENT THAT TAKE CLOPIDOGRELNCT01210248Assaf-Harofeh Medical Center500
已完成
4 期
Impact of CYP2C19 Genotype-guided Clopidogrel and Ticagrelor Treatment on Platelet Function Test and Metabolomics ProfileCoronary Artery Disease (CAD)NCT05516784Universiti Sains Malaysia80
已完成
4 期
Clopidogrel Response and CYP2C19 Genotype in Ischemic Stroke PatientsIschemic StrokeNCT03385538Zealand University Hospital103
已完成
3 期
Clopidogrel and Response Variability Investigation Study 2Coronary Artery DiseaseNCT00822666Assistance Publique - Hôpitaux de Paris109